Sep 20,2017

Hearst invests $75 million in Moffitt's M2Gen

The investment gives a big boost to M2Gen, a key company in the life sciences sector that Tampa and Florida government leaders are working to foster.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 25,2017

Tempus Announces $60 million in Funding Round

Tempus announced that the two-year old company's total funding reached to $130 million after the company raised $70 million in the Series C.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 25,2017

Tempus just landed the year's third-largest funding round at $70M

Tempus, a Chicago startup with its sights set on a more personalized and data-driven approach to cancer treatment, announced on Monday that it has raised a $70 million Series C round. Founded in 2015 by Groupon co-founder Eric Lefkofsky, Tempus uses genomic sequencing, molecular science and Big Data analytics to help doctors pinpoint the treatment options their patients are most likely to respond to. Those predictions are based on analysis of the individual patient�s tumor, as well as treatment results from patients with similar genetic profiles.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Nov 03,2017

PathAI scores $11M to ramp up deep-learning tech, grow team

PathAI, which teamed up with Philips on cancer diagnostics in March, has bagged $11 million in series A financing. The startup will use the funds to build out its team and develop its artificial intelligence-based technology. General Catalyst Partners led the round, while Pillar Companies, Refactor Capital, 8VC, Danhua Capital, and KdT Ventures also participated, Xconomy reported. PathAI is developing deep-learning algorithms for the detection and diagnosis of disease. It aims to help pathologists, who analyze tissue and fluid samples in the lab to diagnose disease, perform their job more accurately and efficiently.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Nov 14,2017

Syapse raises a $30M Series D round to scale its precision medicine program

It started off small. There was a low key $1.5 million seed round and then a $3 million Series A announced in 2013. Fast-forward to 2017 and it�s clear Syapse is working on a much larger scale. On Tuesday, the Palo Alto, California-based software startup closed a $30 million Series D round, for a total of $71 million raised.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Dec 21,2017

Treatment Technologies & Insights (TTI) has raised $1.6M

Treatment Technologies & Insights (TTI), a healthcare technology company, has raised $1.6 million USD through a private offering of securities.

FUNDING CONVERTIBLE NOTE
View Analyst & Ambassador Comments
Go to original news
Dec 22,2017

Acceptance of capital from Japan Post Group

Tokyo-based company, Wellby, which supports the health management of people facing illnesses, has announced that it will carry out a third-party allotment of shares to Japan Post Capital Co., Ltd. and proceed with a partnership with Japan Post Group. By utilizing Japan Post Group's brand and network, Wellby aims to further promote the use of PHR and contribute to medical institutions, regions, and municipalities.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jan 01,2018

Sussex Place Ventures invested in Entia

After winning a �99,000 Smart award from Innovate UK to work up their idea, Entia was awarded a further �139,000 through the Biomedical Catalyst to test its technology�s potential for monitoring cancer patients� response to chemotherapy. That support from Innovate UK also gave Entia the credibility to secure �1 million in private funding and, more recently, venture capital financing led by Sussex Place Ventures. The company�s technology incorporates a range of optical and image analysis techniques to perform a blood count from a pinprick within 60 seconds. In a number of the company�s products, the reading is sent to the cloud so it can be directly uploaded into patient records and accessed by physicians.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Feb 02,2018

Health start-up Medopad raises $28 million after striking over $140 million in China deals

British health tech start-up Medopad has raised $28 million in its first round of financing, after having struck �100 million ($143 million) worth of deals in China with firms including Tencent. Medopad was one of a number of U.K. firms to join British Prime Minister Theresa May on her visit to China this week, as the U.K. leader discussed trade and security with Chinese President Xi Jinping. The Series A round was led by Hong-Kong listed NWS Holdings, the construction and transport flagship of Chinese corporation New World Development. UBS served as a financial advisor to Medopad, overseeing the deal.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 06,2018

AI pathology company Paige.AI raises $25M in funding

Paige.AI, a health technology company that applies artificial intelligence to pathology for cancer diagnosis and treatment, recently announced it landed $25 million in Series A funding, led by Jim Breyer of Breyer Capital. The New York-based company plans to continue to develop computational programs across diagnostic pathology. It will start by focusing on clinical applications in breast cancer, prostate cancer, and other common cancers.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING